{"nct_id":"NCT01472081","title":"Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)","status":"COMPLETED","status_verified_date":"2021-11","start_date":"2012-02-09","start_date_type":"ACTUAL","primary_completion_date":"2016-02-02","primary_completion_date_type":"ACTUAL","completion_date":"2021-06-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["BMY"]}